US SURGEONS SAY "FIRE KESSLER"

9 March 1992

The president of the American Society of Plastic and Reconstruct-ive Surgeons, Norman Cole, has written a letter urging more than 5,000 surgeons to ask that the Commissioner of the US Food and Drug Administration, David Kessler, be removed from deciding whether or not silicone-gel breast implants are safe.

The letter, which complains about Dr Kessler's "attitude," was sent before an expert panel recommended that the implants be used only experimentally. Dr Kessler has two months to decide whether to follow the recommendation.

Dr Cole's letter said Dr Kessler's attitude on the use of silicone, not just silicone-gel breast implants, "genuinely imperils current medical practice," and asked surgeons to urge Health and Human Services Secretary Louis Sullivan to remove him from this issue. "This issue must be decided by an impartial individual." In a later section, the letter urges Dr Sullivan to remove Dr Kessler from the matter "because of his gross mishandling of this issue and his refusal to disclose important medical information."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight